Key Highlights
- Customized Experimental Design
- Efficient and Automated Data Analysis
- Significant Cost and Resource Savings
The Challenge
GSK, a global leader in the pharmaceutical industry, aimed to improve their vaccine development experiments using the Sartorius Ambr250 system. The primary challenge was to design and execute a series of bioassays efficiently within the constraints of their bioreactor setup, which could hold 24 reactors. They needed an experimental design that allowed them to maximize the data extracted from a limited number of runs, with high projection properties that minimized the need for additionalexperiments.
